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Objectives: To examine the effects of telephone-
delivered lifestyle coaching on preventing the
development of type 2 diabetes mellitus (T2DM) in
participants with impaired fasting glucose (IFG).
Design: Cluster randomised trial.
Setting: 40 groups from 17 healthcare divisions in
Japan: companies (31), communities (6) and mixed
settings (3).
Participants: Participants aged 20–65 years with
fasting plasma glucose (FPG) of 5.6–6.9 mmol/L were
invited from the 17 healthcare divisions.
Randomisation: The groups were then randomly
assigned to an intervention or a control arm by
independent statisticians according to a computer-
generated list.
Intervention: The intervention arm received a 1-year
telephone-delivered intervention provided by three
private lifestyle support centres (at different
frequencies: low-frequency (3 times), middle-frequency
(6 times) and high-frequency (10 times) support calls).
The intervention and control arms both received self-
help devices such as a weight scale and pedometer.
Outcomes: Participants were followed up using data
from annual health check-ups and a questionnaire
regarding lifestyle. The primary outcome was the
development of T2DM defined as FPG ≥7.0 mmol/L,
the diagnosis of diabetes, or use of an antidiabetic
drug, confirmed by referring to medical cards.
Results: Of 14 473 screened individuals, participants
were enrolled in either the intervention (n=1240) arm
or control (n=1367) arm. Overall, the HR for the
development of T2DM in the intervention arm during
5.5 years was 1.00 (95% CI 0.74 to 1.34). In the
subanalysis, the HR was 0.59 (95% CI 0.42 to 0.83) in
the subgroup that received phone calls the most
frequently, compared with the control arm. A limitation
of the study includes a lack of blinding.
Conclusions: High-frequency telephone-delivered
lifestyle support could effectively prevent T2DM in
participants with IFG in a primary healthcare setting,
although low-frequency and middle-frequency phone
calls did not.
Trial registration number: This trial has been
registered with the University Hospital Medical
Information Network (UMIN000000662).
BACKGROUND
Type 2 diabetes mellitus (T2DM) continues
to be a major health issue in the 21st
century.1 2 There is an urgent need for
effective strategies to contain this pandemic.
The Finnish Diabetes Prevention Study
(DPS)3 and US Diabetes Prevention Program
Strengths and limitations of this study
▪ Findings were retrieved from a well-designed
cluster randomised controlled trial.
▪ This translational study included large nationwide
samples, a wide range of ages and body mass
index, and real-world settings.
▪ All the data for the study were from health
check-up sites in companies and communities.
We did not include any other biochemical exami-
nations, such as the oral glucose tolerance test.
▪ For identifying impaired fasting glucose and
diagnosing diabetes, we used a single test result
of fasting plasma glucose determined at an
annual health check-up. Because of poor repro-
ducibility, we must be careful when interpreting
a single test result. In addition, we may have
missed diabetic and impaired glucose tolerance
participants with normal fasting but elevated 2 h
plasma glucose levels.
▪ A limitation of the study includes a lack of
blinding.
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(DPP)4 both found that intensive lifestyle intervention
can prevent or delay the development of T2DM in high-
risk populations. However, translating the ﬁndings of
clinical research into real-world primary healthcare prac-
tice on a large scale remains to be achieved.5 In Japan,
to contain increases in lifestyle-related diseases, includ-
ing T2DM, health check-ups targeting metabolic syn-
drome (Tokutei Kenshin) were introduced in 2008 by
the government.6 Through these health check-ups, a
large number of high-risk participants for T2DM are
identiﬁed every year. For those high-risk individuals, life-
style interventions are implemented using a variety of
modalities, including face-to-face individual or group ses-
sions and non-face-to-face healthcare support. It is,
however, questionable to what extent annual health
check-ups contribute towards overcoming the pandemic
of T2DM.7 There is a large gap between identifying
high-risk participants and preventing diabetes in the real
world. Given the limited resources for primary health-
care, cost-effectiveness is a key issue. Evidence-based
effective and efﬁcient prevention programmes that are
easily accessible are needed. Telephone counselling
support would make it possible to deliver lifestyle inter-
vention widely,8–10 at low cost, yet in a personalised
manner. If proven effective, it would be a promising tool
for national strategies against T2DM. The Japan
Diabetes Outcome Intervention Trial-1 ( J-DOIT1) is a
nationwide, pragmatic cluster randomised controlled
trial.11 12 The aim of this study was to investigate
whether goal-focused lifestyle coaching delivered by tele-
phone can effectively prevent the development of T2DM
in high-risk individuals in a primary healthcare setting.
We also aimed to clarify the effectiveness of telephone




The protocol, rationale and recruitment of the study
participants are described elsewhere.12 A cluster rando-
mised controlled trial was conducted at healthcare divi-
sions in companies and communities that carry out
health check-ups for employees and residents.
Randomisation occurred at the level of branches of the
healthcare division to avoid contamination between the
intervention and control arms.
Recruitment
Healthcare divisions
By advertising on the internet or through direct contact,
we invited healthcare divisions in communities and at
worksites (companies) to participate in the study. The
inclusion criteria for the divisions were: (1) health
check-ups were conducted according to guidelines by
the Health Promotion Law, (2) there were 2000 or more
examinees annually, (3) the study group could be pro-
vided with health check-up data every year starting from
2006 and (4) lifestyle surveys could be conducted every
year using a questionnaire prepared by the study team.
Randomisation
The branches (groups) of healthcare divisions recruited
from communities and companies were the randomisa-
tion unit. The groups were then randomly assigned to
an intervention or a control arm by independent statisti-
cians according to a computer-generated list. The
groups were notiﬁed of their allocation status before
study participants were recruited.
Participants
Using the 2006 health check-up data, candidates who
met the inclusion criteria were identiﬁed in each group.
Inclusion criteria included an age of 20–65 years and
impaired fasting glucose (IFG), deﬁned as a fasting
plasma glucose (FPG) concentration of 100–125 mg/dL
(5.6–6.9 mmol/L). Exclusion criteria included diag-
nosed diabetes, a history of taking antidiabetic agents
and glycated haemoglobin of ≥6.5%.13 Women with a
history of gestational diabetes could be enrolled.
Physical or medical conditions that do not allow exer-
cise, pregnancy or possible pregnancy, T1DM, liver cir-
rhosis or chronic viral hepatitis, and the use of a cardiac
pacemaker, were also included in exclusion criteria. The
recruitment of the participants started on 31 March
2007 and ended in March 2011.
Lifestyle support centre
We outsourced some parts of the study to three existing
private companies (Tokio Marine & Nichido Medical
Service Co, Ltd, Tokyo, Japan; National Education
Association, Inc, Visit Health Co, Ltd, Tokyo, Japan; and
Meiji Yasuda System Technology Co, Ltd, Tokyo, Japan).
They are all practising healthcare services. They partici-
pated in this study as lifestyle support centres, managing
recruitment and enrolment of study participants and
the lifestyle intervention.
Intervention arm
The goals for lifestyle change were set for each partici-
pant referring to the following four points: (1) habitual
exercise (10 000 steps or more per day or 60 min or
more per week of accumulated moderate exercise),14 15
(2) achievement and maintenance of an appropriate
body weight (a 5% reduction in body weight in partici-
pants with a body mass index (BMI) ≥25 kg/m2 or a 3%
reduction in participants with a BMI of 23.0–24.9 kg/
m2), (3) habitual intake of dietary ﬁbre (ﬁve or more
servings of vegetables per day or 350 g or more of vege-
tables per day)16 and (4) restrictions on alcohol intake
(1 ‘go’ (180 mL) or less per day in terms of Japanese
sake: 1 ‘go’ of Japanese sake contains 23 g of ethanol17).
After setting goals, a weight scale (HBF-354 IT-2, Omron
Healthcare Co, Ltd) and a pedometer (HJ-710 IT,
Omron Healthcare Co, Ltd) with a storage function
were provided. They could send accumulated data to the
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lifestyle support centres via a transmitter (DC-100, JMS
Co, Ltd). The participants periodically received newslet-
ters from the lifestyle support centres, which included
health-related information and messages to regularly
encourage them to undergo health check-ups.
Telephone-delivered lifestyle support was given by
healthcare providers (nurses, public health nurses and
dieticians) over a 1-year period through one of the three
lifestyle support centres. Participating groups were allo-
cated to one of the three lifestyle support centres (desig-
nated as centre A, centre B and centre C). Participants
received lifestyle support calls 3 times from centre A, 6
times from centre B and 10 times from centre C over
1 year, with the length of each call being between 15
and 30 min. Centres A and C also sent monthly advice
sheets by mail. We held educational sessions on diabetes
and its prevention for healthcare providers in each
support centre and training sessions to improve their
telephone counselling skills with motivational interview-
ing. The staff at each centre conducted the baseline
assessment (lifestyle, motivation for lifestyle modiﬁca-
tions, stage of change, health status and knowledge of
diabetes) and set the personal action plan: (1) list of
speciﬁc goals in behavioural terms, coaching in realistic
and measurable goals to increase self-efﬁcacy, (2) discus-
sion of advantages and disadvantages of healthy behav-
iour changes, (3) identiﬁcation of barriers to healthy
behaviour changes and (4) discussion of
problem-solving approaches to improve ability to address
barriers. The participants were encouraged to measure
their body weight and count footsteps every day, and
send the accumulated data to the lifestyle support
centres via a transmitter. The healthcare provider moni-
tored progress towards the participant’s goals regularly
and gave advice by phone or mail.
Control arm
After setting the goals, a weight scale and pedometer
were also provided for participants in the control arm.
Participants in the control arm periodically received
newsletters on diabetes and diabetes prevention but did
not receive telephone-delivered intervention.
Participants were encouraged, through newsletters, to
undergo annual health check-ups.
Outcome measures
Participants were followed up annually using the data
from an annual health check-up, and a questionnaire
regarding health and lifestyle. The primary outcome was
the development of diabetes in participants whose FPG
concentration was 5.6–6.9 mmol/L (100–125 mg/dL) at
baseline. The development of T2DM was deﬁned as: (1)
a rise in FPG to a level ≥7.0 mmol/L (126 mg/dL) as
revealed in the annual follow-up health check-ups and
(2) a diagnosis of diabetes or use of antidiabetic drugs
as reported in the annual questionnaire with conﬁrm-
ation by referring to medical records. Overweight (23.0–
24.9) and obesity (≥25) were deﬁned based on BMI
(kg/m2) using the WHO Western Paciﬁc Regional
Ofﬁce criteria.18 19 Other outcomes included a change
in body weight, success of achieving goals, and adher-
ence to and satisfaction with telephone intervention.
Programme participation was evaluated by the number
of responses to phone calls (percentage). Good adher-
ence was deﬁned as >80%. Total and telephone-related
costs were calculated. Satisfaction of participants with
the support service was assessed based on six items
(overall; provision of knowledge on diabetes and dia-
betes prevention; dietary support; exercise support;
wanting to continue to receive telephone support in the
future; recommending the telephone support service to
other people such as family members and friends). The
responses were rated on a six-point Likert scale (ranging
from 1 (strongly disagree) to 6 (strongly agree)).
Dropout cases in the present study include: (1) partici-
pants who have not undergone an annual health
check-up after enrolment and (2) participants who have
lost contact with the study team.
Analysis and power
Masking of treatments was not possible because imple-
mentation of the intervention was obvious. Data analysts
were not blinded after the database was locked for
ﬁnal analysis. The analyses were conducted on an
intention-to-treat basis, using Statistical Package for SAS
V.9.3 (SAS Inc, Cary, North Carolina, USA) and Statistical
Package for Social Science software V.20.0 (IBM SPSS
Inc, Chicago, Illinois, USA). Survival curves for the devel-
opment of diabetes were estimated by the Kaplan–Meier
method. The log-rank test was also used. We took into
account the clustering effect in the main outcome ana-
lysis and subanalysis using the LWA model (Lee, Wei and
Amato).20 Cox regression analysis was used to calculate
the HR and 95% CI. The subanalyses were performed
within each lifestyle support centre because each lifestyle
support centre was in charge of each intervention and
control arm. Also, Cox regression analysis was adjusted
for baseline FPG concentration. Values are presented as
the mean±SD. Student t test (or the Mann-Whitney U
test according to the frequency distribution of the vari-
able) was used to compare the means (or distributions)
of the two study arms for continuous variables. A χ2 test
was used to compare proportions for categorical vari-
ables. Missing data on other outcomes were handled
using the last observation carried forward imputation
technique. The p value <0.05 was considered signiﬁcant.
Based on the available prospective data from the
Japanese population, the yearly incidence of diabetes
among the high-risk group varies between 2% and 7%.21
When calculated on the assumption that the annual inci-
dence of diabetes is 4% in the control arm and the inter-
vention reduces the incidence by 50%, the number is
1100 with an α of 5% and a power of 90%. When the
intra-cluster correlation coefﬁcient (ICC) and cluster size
(number of individuals in each cluster) are assumed to
be 0.02 and 60, participants and the number of clusters
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will be 2398 and 40, respectively. Assuming that the
dropout rate is 30%, 3426 participants are needed.
RESULTS
Participant enrolment and baseline characteristics
Forty-three groups, formed from 17 healthcare divisions
in companies or in communities across the country,
were randomly assigned to a control arm (21 groups) or
an intervention arm (22 groups) between March 2007
and February 2008. Approximately 230 000 individuals
(male, 85%) underwent health check-ups in those 43
groups in 2006. Two groups in the intervention arm and
one group in the control arm were excluded because
FPG levels were not available at baseline. Among the
groups, 14 473 participants (7494 in the control and
Table 1 Baseline characteristics of control and intervention groups and participants
Variables Intervention arm (20 groups, n=1240) Control arm (20 groups, n=1367)
Group factors at baseline
Settings (total number of participants)
Company setting 16 groups (n=1121) 15 groups (n=1197)
Community setting 3 groups (n=94) 3 groups (n=92)
Mixed sitting 1 group (n=25) 2 groups (n=78)
Participants factors at baseline
Age, year 48.9 (7.8) 48.9 (7.5)
Male, % 82.5 84.1
Body mass index, kg/m2 24.4 (3.2) 24.3 (3.1)
Lifestyle goals
Habitual exercise* 51.7 52.4
Dietary fibre intake† 0.0 0.2
Restrictions on alcohol intake‡ 42.7 40.7
Values are number, percentage or mean (SD).
*Self-reported habitual exercise was defined as 10 000 steps or more per day or 60 min or more per week of accumulated moderate exercise.
†Habitual intake of dietary fibre (five or more dishes of vegetables per day or 350 g or more of vegetables per day).
‡Restrictions on alcohol intake (1 ‘go’ (180 mL) or less per day in terms of Japanese sake, 1 ‘go’ of Japanese sake contains 23 g ethanol).
Figure 1 CONSORT flow
diagram of Japan Diabetes
Outcome Intervention Trial-1
( J-DOIT1).
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6979 in the intervention arm) received an invitation
letter to participate in the study. Finally, 2607 partici-
pants were enrolled, with 1240 in the intervention and
1367 in the control arm (table 1) across the country (eg,
Hokkaido, Tohoku, Kanto, Chubu, Kansai, Chugoku,
Shikoku, Kyusyu and Okinawa ). The overall consent
rate was approximately 18% with no difference between
the study arms (ﬁgure 1). The median age, BMI and
FPG level of the study participants were 49 years,
24.3 kg/m2 and 5.9 mmol/L, respectively, and 83.4%
were men. There was no difference in the proportion of
lifestyle goals (eg, dietary ﬁbre intake and alcohol
intake) at baseline between arms. Also, there was no dif-
ference in the proportion of lifestyle goals at baseline
between arms within each centre. The dropout rate
during the study was 17.5% for the intervention arm
and 20.9% for the control arm.
Primary outcomes
During a median follow-up period of 4.2 years, T2DM
developed in 115 participants in the intervention arm
(9.3%) and 132 participants in the control arm (9.7%).
Overall, the HR for the development of T2DM in the
intervention arm during 5.5 years was 1.00 (95% CI 0.74
to 1.34). In the subanalysis of the three lifestyle support
centres, the HR was signiﬁcantly reduced to 0.59 (95%
CI 0.42 to 0.83; p=0.02) for centre C, which provided 10
telephone calls, while no beneﬁcial effects on the inci-
dence were found for centres A and B, which made tele-
phone calls less frequently. The HR was 1.41 (95% CI
0.85 to 2.32; p=0.18) for centre A and 1.19 (95% CI 0.77
to 1.84; p=0.38) for centre B (ﬁgure 2, table 2).
Overall, the baseline FPG adjusted for HR was 0.97
(95% CI 0.69 to 1.38; p=0.878). The baseline FPG
adjusted HR was 0.56 (95% CI 0.34 to 0.94; p=0.028) for
centre C, 1.55 (95% CI 0.82 to 2.93; p0.176) for centre
A and 1.12 (95% CI 0.72 to 1.74; p=0.617) for centre B.
Other outcomes
The decrease in body weight after 1 year intervention
and at the end of the trial was modest, but signiﬁcantly
greater in the intervention arm than in the control arm
(table 3). After 1 year intervention and at the end of the
trial, the percentages of the participants who met the
goal of ‘weight reduction’, ‘dietary ﬁbre intake’ and
‘restrictions on alcohol intake’, were signiﬁcantly higher
in the intervention arm compared with the control arm.
On the contrary, as to ‘habitual exercise’, no difference
was found between the arms. When comparing each
centre separately, centre C, which provided high-
frequency support calls, showed the most beneﬁcial
results. In centre C, the proportion of participants
within the normal range (FPG <5.5 mmol/L) was signiﬁ-
cantly higher in the intervention than control arm after
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Adherence and satisfaction
The mean number of responses to the calls during the
1 year period was 2.8±0.6 (range 1–3) in centre A, 5.2
±1.9 (range 1–6) in centre B and 8.2±3.5 (range 1–13)
in centre C. The rates of good adherence were 91.4%,
82.7% and 81.1%, for each centre, respectively.
Satisfaction of the participants with the support service
was assessed in terms of six items. The score was slightly
but signiﬁcantly higher for each item in centre C (satis-
faction score, evaluated on a six-point Likert scale on a
maximum scale of 36, centre A: 24.2 of 36, centre B:
24.0 of 36, centre C: 27.0 of 36).
Adverse events
There was no difference in the incidence of adverse
events between the intervention and control arms (1.9%
vs 1.8%, respectively, p=0.73). The numbers of partici-
pants who developed cancer, musculoskeletal system pro-
blems, ischaemic heart disease, stroke and other adverse
events were 5, 6, 1, 3 and 9 in the intervention arm, and
8, 3, 2, 2 and 9 in the control arm, respectively. Four
cases of musculoskeletal system problems in the inter-
vention arm and one case of musculoskeletal problems
in the control arm might have been related to the study
treatment, while other adverse events were not. There
was no difference in the incidence of adverse events
among the three centres.
DISCUSSION
It has become mandatory for all Japanese adults to
undergo health check-ups at least once a year in work-
places or communities. Health check-ups are therefore
becoming a routine part of healthcare. Through this
health check-up, we recruited a large number of partici-
pants at high risk for T2DM from healthcare divisions
across Japan. The present study was thus expected to
generate much evidence regarding antidiabetes strat-
egies. We included not only overweight and obese parti-
cipants, but also participants with a BMI of <23 kg/m2.
Therefore, the BMI ranged widely from <18.5 to >30 kg/
m2 in our study participants, with an average value of
24.3. Compared with Western populations, obesity is less
common in Japanese in general.22 It has also been
reported that about 25% of participants with impaired
glucose tolerance (IGT) have normal or even under-
weight categories of BMI.23 It seems that the relationship
between BMI and the risk of diabetes is not straightfor-
ward in Japanese populations. Thus, we did not set the
eligibility criteria in terms of BMI. It would be of interest
Figure 2 Kaplan–Meier plot for developing diabetes among all, low-frequency, middle-frequency and high-frequency calls.
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to study the incidence of diabetes and assess what strat-
egies are effective to prevent the development of dia-
betes in those with a lower BMI.
All available data for the study were from health
check-up sites in companies and communities. We did
not include any other biochemical examinations, such
as the oral glucose tolerance test. With an expanding
population of patients with lifestyle-related diseases,
healthcare businesses have grown and now play signiﬁ-
cant roles in combating such diseases. Therefore, to
prevent T2DM in a real-world setting, we outsourced the
implementation of lifestyle intervention to private
healthcare businesses. Because of the large sample size,
we employed three companies as lifestyle support
centres in this study. The telephone-delivered lifestyle
support was provided over a 1 year period by one of the
three lifestyle support centres. Each company used its
own intervention schedule approved by the study group.
The major difference in the protocol among the three
centres was in the number of contacts by telephone.
Main findings
Overall, the study could not prove the effectiveness of a
1-year telephone-delivered lifestyle intervention pro-
gramme to reduce the development of T2DM in partici-
pants with IFG. Changes in lifestyle by the 1 year
intervention were modest. A small but signiﬁcant
amount of weight reduction was achieved in the inter-
vention arm after the 1 year intervention and at the end
of the trial. The proportions of participants who
achieved and maintained an appropriate body weight,
who achieved the goal of vegetable intake and who
achieved the goal of alcohol intake, were all slightly
higher in the intervention compared with the control
arm. In this study, the control arm received a weight
scale and a pedometer with a storage function, just as

















1 year after intervention −1.8 (3.6)* 71.6* 56.2* 5.6* 47.2* 42.1
End of trial −1.1 (3.4)* 60.7 41.1* 12.3* 49.0 32.5
Control arm
1 year after intervention −1.0 (3.4) 66.9 51.7 0.5 41.6 38.5
End of trial −0.6 (3.6) 59.2 36.1 6.0 45.6 32.4
Centre A
Intervention arm
1 year after intervention −1.8 (3.2)* 74.8 58.8 2.2 40.3 31.0
End of trial −1.2 (3.1)* 60.0 41.6 8.6 41.3 26.8
Control arm
1 year after intervention −1.1 (3.3) 69.8 56.2 0.5 35.7 27.2
End of trial −0.4 (3.5) 60.7 37.5 6.2 41.1 20.5
Centre B
Intervention arm
1 year after intervention −1.6 (3.8)* 72.3 50.0 2.1* 44.9* 43.9
End of trial −0.9 (3.4) 62.0 37.8 7.0* 46.8 33.1
Control arm
1 year after intervention −0.9 (3.3) 66.8 48.7 0.5 37.6 43.9
End of trial −0.6 (3.4) 59.3 33.8 4.3 43.2 37.2
Centre C
Intervention arm
1 year after intervention −2.0 (3.6)* 68.0 61.7* 12.4* 55.8 49.4*
End of trial −1.3 (3.5)* 59.7 44.9* 21.8* 57.5 36.5
Control arm
1 year after intervention −0.9 (3.6) 65.4 52.9 0.6 50.3 38.0
End of trial −0.6 (3.8) 58.2 38.3 8.1 51.1 33.1
Values are the means (SD) or percentage.
*p<0.05 (vs control arm).
†Self-reported habitual exercise was defined as 10 000 steps or more per day or 60 min or more per week of accumulated moderate exercise.
‡Achievement and maintenance of an appropriate body weight (a 5% reduction in body weight in participants with body mass index
≥25 kg/m2 or a 3% reduction in participants with 23.0–24.9 kg/m2).
§Habitual intake of dietary fibre (five or more dishes of vegetables per day or 350 g or more of vegetables per day).
¶Restrictions on alcohol intake (1 ‘go’ (180 mL) or less per day in terms of Japanese sake, 1 ‘go’ of Japanese sake contains 23 g ethanol).
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the intervention arm did. This was done to minimise the
potential for the greater attrition of participants in the
control arm. Thus, it seems likely that the use of these
devices markedly contributed to the present ﬁndings on
the lifestyle changes and incidence of diabetes.
Therefore, to obtain additional interventional effects,
intensive intervention would be needed. Consistent with
this speculation, subanalysis of the three lifestyle support
centres revealed that the HR was signiﬁcantly reduced to
0.59 with centre C, which provided 10 telephone calls,
while no beneﬁcial effects on the incidence were found
with centres A and B, which made telephone calls less
frequently. From these ﬁndings, it would be reasonable
to conclude that remote intervention delivered by tele-
phone, if provided frequently, could be a beneﬁcial
measure for preventing the development of T2DM on a
large scale. These ﬁndings are consistent with a previous
study in obese patients with metabolic syndrome involv-
ing frequent telephone interventions (16-session core
curriculum in year 1, 12-session continued telephone
contact in year 2 plus telephone coaching sessions).24
Thus, we could propose that lifestyle support by tele-
phone given monthly for 1 year might be a standard for
effective intervention.
Strengths and limitations
The strengths of this translational study are that it
included large nationwide samples, with wide range of
ages and BMI, and was conducted in real-world settings.
We could follow-up the study participants for 3 years
after the intervention. Much evidence has been gener-
ated to contain ongoing T2DM, endemic in our
country; several real-world translational studies based on
intensive diabetes programmes have thus far provided
important information necessary to reduce costs and
increase accessibility.25–27 However, the main outcome of
many of those studies was weight reduction, not develop-
ment of diabetes.28
The study also had several potential limitations. First,
all data were from health check-up sites in companies
and communities. We did not include any other bio-
chemical examinations, such as the oral glucose toler-
ance test. For identifying IFG and diagnosing diabetes,
we used a single test result of FPG determined at an
annual health check-up. Because of poor reproducibil-
ity, we must be careful when interpreting a single test
result.29 In addition, we may have missed diabetic and
IGT participants with normal fasting but elevated 2 h
plasma glucose levels.30 Second, lifestyle data were
based on self-reported questionnaires. Finally, the parti-
cipants were predominantly from workplaces and we
did not succeed in recruiting more participants from
communities. Since men outnumber women in many
workplaces in Japan, the study population was predom-
inantly male. This bias may limit the generalisability of
our results.
In summary, the present ﬁndings indicate that remote
intervention delivered by telephone, if it is provided
frequently, could be a beneﬁcial measure in preventing
the development of T2DM in a real-world primary care
setting. Telephone-delivered lifestyle support by health-
care providers implemented monthly for 1 year might
be a standard method for effective intervention.
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